# FibroBiologics, Inc.: Form 8-K, filed Apr 17, 2026

- Company: [FibroBiologics, Inc.](/companies/fblg.md) (CIK 1958777)
- Form: 8-K
- Filed: 2026-04-17
- Accepted by EDGAR: Apr 17, 2026, 20:05 ET
- Period: 2026-04-16
- Accession: 0001193125-26-161507
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1958777/000119312526161507/fblg-20260416.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1958777/000119312526161507/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1958777/000119312526161507/fblg-20260416.htm

Filed Apr 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-161507. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.
